Jupiter Neurosciences, Inc. (JUNS)
Nasdaq: JUNS · Pharmaceutical Preparations · Jupiter, FL · filing with the SEC since 2016
Who owns Jupiter Neurosciences, Inc.
As filed with the SECHolders of 5% or more
1
PharmAla Biotech Holdings Inc. holds 10.1% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed Oct 26, 2026 says.
Directors and officers
11
report now, of 11 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
PharmAla Biotech Holdings Inc.
SCHEDULE 13G/A · filed Oct 26, 2026 · Common Stock, par value $0.0001 per share · 17.3% in Sep 22, 2026
Orca Capital AG
SCHEDULE 13G/A · filed Aug 28, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 8.4% in Aug 28, 2026
What JUNS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Aquanova AG
An entity · legal entity · owns, named in the 10-K filed Apr 1, 2026
Entity One
An entity · legal entity · owns, named in the 10-K filed Apr 1, 2026
Entity Three
An entity · legal entity · owns, named in the 10-K filed Apr 1, 2026
Entity Two
An entity · legal entity · owns, named in the 10-K filed Apr 1, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.